HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A meta-analysis of lentinan injection combined with chemotherapy in the treatment of nonsmall cell lung cancer.

AbstractOBJECTIVE:
To systematic review and analysis the clinical efficacy and toxicity of lentinan injection combined with chemotherapy in the treatment of nonsmall cell lung cancer (NSCLC).
MATERIALS AND METHODS:
The databases of PubMed and CNKI were electronic searched with the free text word of lung cancer/NSCLC and lentinan. The prospective clinical study reporting the clinical efficacy and safety of lentinan injection combined with chemotherapy in the treatment of NSCLC were reviewed and included in this meta-analysis. The combined treatment efficacy and toxicity of lentinan injection combined with chemotherapy were pooled by Stata 11.0 software.
RESULTS:
Twelve clinical studies of lentinan injection combined with chemotherapy in the treatment of NSCLC with 458 controls and 492 NSCLCs patients were finally included in this meta-analysis. The pooled results indicated that the objective response rate was significant improved in the lentinan injection combined chemotherapy group compared with chemotherapy group only (relative risk [RR] = 1.31, 95% confidence interval [CI]: 1.14-1.52). The chemotherapy-related toxicity of III/IV gastrointestinal reaction (RR = 0.54, 95% CI: 0.43-0.68) and III/IV granulocytopenia (RR = 0.65, 95% CI: 0.51-0.70) were significant decreased in the combined group.
CONCLUSION:
Lentinan injection combined chemotherapy significant increase the objective response rate and decreased the chemotherapy-related toxicity.
AuthorsX Yin, J Ying, L Li, H Zhang, H Wang
JournalIndian journal of cancer (Indian J Cancer) Vol. 52 Suppl 1 Pg. e29-31 (Nov 2015) ISSN: 1998-4774 [Electronic] India
PMID26548936 (Publication Type: Journal Article, Meta-Analysis, Systematic Review)
Chemical References
  • Antineoplastic Agents
  • Lentinan
Topics
  • Antineoplastic Agents (therapeutic use)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Carcinoma, Non-Small-Cell Lung (drug therapy)
  • Humans
  • Lentinan (therapeutic use)
  • Lung Neoplasms (drug therapy)
  • Prospective Studies
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: